| A Pt (IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastoma JL Jimenez-Macias, YC Lee, E Miller, T Finkelberg, M Zdioruk, G Berger, ... Journal of Controlled Release 352, 623-636, 2022 | 8 | 2022 |
| Cytomegalovirus infection of glioblastoma cells leads to NF-κB dependent upregulation of the c-MET oncogenic tyrosine kinase H Krenzlin, M Zdioruk, MO Nowicki, T Finkelberg, N Keric, ... Cancer letters 513, 26-35, 2021 | 2 | 2021 |
| PPRX-1701, a nanoparticle formulation of 6′-bromoindirubin acetoxime, improves delivery and shows efficacy in preclinical GBM models M Zdioruk, JL Jimenez-Macias, MO Nowicki, KE Manz, KD Pennell, ... Cell Reports Medicine 4 (5), 2023 | 1 | 2023 |
| Pt (IV)-M13, a blood-brain-barrier penetrant macrocyclic peptide-platinum (IV) conjugate, leads to enhanced drug uptake and efficacy in murine glioblastoma models JL Jimenez-Macias, YC Lee, T Finkelberg, G Berger, M Nowicki, CF Cho, ... Cancer Research 82 (12_Supplement), 5329-5329, 2022 | | 2022 |
| DDRE-47. ASSESSMENT OF BRAIN PENETRANCE, BIODISTRIBUTION, AND EFFICACY OF PLATINUM (IV)-CONJUGATED FLUORINATED MACROCYCLIC CELL-PENETRATING PEPTIDES IN A MURINE GLIOBLASTOMA MODEL J Jimenez Macias, YC Lee, T Finkelberg, M Zdioruk, G Berger, M Nowicki, ... Neuro-Oncology 23 (Supplement_6), vi84-vi85, 2021 | | 2021 |
| DDRE-35. PRE-CLINICAL ASSESSMENT OF PPRX-1701, A NANOPARTICLE FORMULATION OF 6-BROMO-ACETOXIME, FOR THE TREATMENT OF GLIOBLASTOMA M Zdioruk, T Finkelberg, M Nowicki, B Wu, Y Takeda, A Chiocca, S Lawler Neuro-Oncology 23 (Suppl 6), vi82, 2021 | | 2021 |
| DDRE-47. ASSESSMENT OF BRAIN PENETRANCE, BIODISTRIBUTION, AND EFFICACY OF PLATINUM (IV)-CONJUGATED FLUORINATED MACROCYCLIC CELL-PENETRATING PEPTIDES IN A MURINE GLIOBLASTOMA MODEL JJ Macias, YC Lee, T Finkelberg, M Zdioruk, G Berger, M Nowicki, CF Cho, ... Neuro-Oncology 23 (Suppl 6), vi84, 2021 | | 2021 |
| Investigating the role of cytomegalovirus in the potentiation of glioblastoma growth using multiple murine models T Finkelberg Boston University, 2020 | | 2020 |
| PPRX-1701, a Nanoparticle Formulation of 6’-Bromoindirubin Acetoxime, Improves Delivery and Shows Efficacy in Immune Competent Preclinical GBM Models M Zdioruk, OM Nowicki, M Koch, T Finkelberg, B Wu, P Boucher, ... Improves Delivery and Shows Efficacy in Immune Competent Preclinical GBM Models, 0 | | |
